Taiwan Jade Ginseng (Panax ginseng)

Taiwan Jade Ginseng is a cultivar of Panax ginseng developed in Taiwan, containing ginsenosides — triterpenoid saponins that modulate adrenal cortex activity and influence HPA axis signaling. No published human clinical trials exist for this specific cultivar, so its benefits are inferred from broader Panax ginseng research rather than direct evidence.

Origin & History

Taiwan Jade Ginseng is listed as a cultivar variant of Panax ginseng, but no specific information about this particular cultivar is available in the current research. The research dossier contains information about other Panax ginseng cultivars from Korea and China, but lacks details about Taiwan-specific varieties.

Historical & Cultural Context

No historical or cultural context for Taiwan Jade Ginseng is provided in the research dossier. The available information discusses only modern cultivation practices for Korean cultivars developed between 2002-2012.

Health Benefits

• No clinical health benefits can be reported - the research dossier contains no human studies or clinical trials for this cultivar
• No efficacy data available - the provided research focuses only on cultivation characteristics of other ginseng varieties
• No safety profile established - the research lacks toxicology or adverse event data
• No active compound data - ginsenoside or other bioactive compound concentrations not provided
• No traditional use documentation - historical medical applications not included in the research

How It Works

Ginsenosides in Panax ginseng, including protopanaxadiols (Rb1, Rc, Rd) and protopanaxatriols (Rg1, Re, Rf), bind to glucocorticoid receptors and modulate nitric oxide synthase activity, influencing vasodilation and stress response. Rg1 has been shown to act as a phytoestrogen, binding estrogen receptor-beta, while Rb1 inhibits voltage-gated calcium channels in smooth muscle. These mechanisms are documented for the Panax ginseng species broadly; whether Taiwan Jade Ginseng's specific ginsenoside profile differs meaningfully from other cultivars has not been characterized in published research.

Scientific Research

No clinical trials, randomized controlled trials, or meta-analyses were found in the provided research for Taiwan Jade Ginseng or any other Panax ginseng cultivar. The available data focuses exclusively on agricultural cultivation parameters and yield comparisons between Korean and Chinese cultivars.

Clinical Summary

No clinical trials or human studies have been conducted specifically on the Taiwan Jade Ginseng cultivar, making it impossible to report quantified efficacy data for this variety. The existing research dossier for this cultivar addresses only agricultural and cultivation characteristics rather than pharmacological outcomes. General Panax ginseng research — including randomized controlled trials in populations of 30–300 participants — has examined cognitive performance, immune modulation, and fatigue, but these findings cannot be directly extrapolated to Taiwan Jade Ginseng without cultivar-specific phytochemical profiling. The evidence base for this specific ingredient must be rated as insufficient until dedicated clinical research is conducted.

Nutritional Profile

Taiwan Jade Ginseng (Panax ginseng cultivar) nutritional composition is not independently documented in available literature; however, as a Panax ginseng cultivar, general ginseng root composition provides a reference baseline. Dried ginseng root typically contains approximately 60-70% carbohydrates (predominantly polysaccharides and starches), 12-14% protein, 1-2% fat, and 2-4% crude fiber. Key bioactive compounds characteristic of Panax ginseng species include ginsenosides (triterpene saponins, typically 2-3% of dry weight in standard cultivars, with Rb1, Rb2, Rc, Rd, Re, and Rg1 being the most prevalent), polyacetylenes (panaxynol, panaxydol), polysaccharides (ginsenans), and peptidoglycans. Minerals present in ginseng root generally include potassium (~400-500 mg/100g dry weight), calcium (~60-80 mg/100g), magnesium (~20-30 mg/100g), phosphorus (~150-200 mg/100g), and trace amounts of iron, zinc, and manganese. B-vitamins including niacin and thiamine are present at low concentrations. Specific ginsenoside profile, total saponin content, and precise micronutrient concentrations for the Taiwan Jade cultivar specifically are not established in available research; cultivar-specific growing conditions in Taiwan may alter ginsenoside ratios compared to Korean or Chinese reference standards. Bioavailability data for this specific cultivar is absent.

Preparation & Dosage

No dosage information is available in the provided research. The research contains only cultivation data such as plant heights and root yields for other ginseng cultivars. No extraction methods, standardization procedures, or clinical dosing protocols are documented. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cannot recommend synergistic ingredients without clinical or traditional use data

Safety & Interactions

Because no clinical studies exist for Taiwan Jade Ginseng specifically, its safety profile has not been formally established for this cultivar. Based on general Panax ginseng data, common side effects include insomnia, headache, gastrointestinal upset, and elevated blood pressure at higher doses. Panax ginseng broadly may potentiate anticoagulants such as warfarin by inhibiting platelet aggregation, and may interact with MAO inhibitors, hypoglycemic agents, and immunosuppressants. Pregnant and breastfeeding individuals are advised to avoid use due to the presence of ginsenoside Rb1, which has shown teratogenic effects in animal models.